Multidrug resistant tuberculosis: prevalence and risk factors in districts of Metema and West Armachiho, Northwest Ethiopia
The aim of this study was to assess the prevalence of MDR-TB and associated risk factors in West Armachiho ...
Strategies Based on Evidence to Rationalize the High Cost Drugs National List in the Dominican Republic
In 2014, the budget for high cost drugs in the Dominican Republic was USD 107 million, accounting for 51% of the Ministry of Health (MoH) bud...
Integration of HIV in Child Survival Platforms: A Novel Programmatic Pathway towards the 90–90–90 Targets
In this commentary, the authors discuss why integrating HIV testing, treatment and care into child survival platforms is important, as well as its ...
Implementation of 350-2500 nm Diffuse Reflectance Spectroscopy and High Performance Thin Layer Chromatography to Rapidly Assess Manufacturing Consistency and Quality of Cotrimoxazole Tablets in Tanzania
The objective of this study was to assess the quality of cotrimoxazole tablets produced by a Tanzanian manufacturer by a newly instituted quality a...
![[An Accredited Medicines Stores (AMS) seller receives an infrared thermometer to use in Ebola and other outbreak surveillance.]](https://msh.org/wp-content/uploads/2016/01/gates-sdsi_ebola65fe9cfa341a4366bb05203d401e90cepng_png_autocropped.jpg)
The Accredited Medicine Stores in Liberia: Their Role in the Ebola Crisis
Management of Medicines Benefit Programs in Low- and Middle-Income Settings
The Management of Medicines Benefit Programs in Low- and Middle-Income Settings manual serves as a primer for managers, government officials, or consu...
QuanTB Helps Ensure Medicines Availability, Averts Waste, and Saves Money in Bangladesh
Uganda Health Supply Chain Briefer
The USAID-funded and MSH-led Uganda Health Supply Chain (UHSC) project aims to improve the health of all Ugandans by increasing the availability, acce...
Tuberculosis Retreatment "Others" in Comparison with Classical Retreatment Cases: A Retrospective Cohort Review
Retreatment ‘others’ refer to all TB cases who were previously treated but with unknown outcome of that previous treatment or who have return...
Reducing the Price of Treatment for Multidrug-Resistant Tuberculosis through the Global Drug Facility
In 2013 the Global Drug Facility reduced the price of the second-line drugs it supplies for multidrug-resistant tuberculosis (MDR TB): ...